The Scientist spoke with the UK’s chief veterinary officer, Christine Middlemiss, about this winter’s high bird flu prevalence, the effects of the disease, and efforts to combat it.
Epidemiological research suggests that a flu diagnosis might be one factor in the eventual onset of the neurodegenerative disease, but experts say it doesn’t prove a causal relationship.
This Technique Talk will discuss the challenges in breast cancer research and treatment and how to develop new methods and resources for functional precision medicine and cancer drug development.
Fate-seq utilizes long custom oligos to screen viral genome stability with an NGS workflow. Using it, researchers screened genomic sequences long enough to identify these complex secondary structures in the SARS-CoV and SARS-CoV-2 genome.
Do you know the 4-letter word for “cobra’s trademark”?
Thanks for reading! I’m Christie, and I curate and edit this newsletter. My inbox is always open, so if you have thoughts or ideas about this newsletter or tips for our news team, I’d love to hear from you.
Never miss an email from The Scientist. Click hereto add The Scientist to your safe-sender list.
The Scientist,1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801 Toll-Free: (888) 781-0328 | Phone: (705) 528-6888 Email: privacy@the-scientist.com
.png?upscale=true&width=602&upscale=true&name=Bio-Techne-%20Flurokines%20For%20CAR-T%20Research-%20Shop%20Now%20(Boombox).png)
